Larvol Delta - Coherus-BioSciences-Reports-Fourth-Quarter-Full-Year-2023-Financial-Results-and-Provides-Current-Business-Update

Yusimry (adalimumab-aqvh) - Coherus Biosci

Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva

https://www.globenewswire.com/news-release/2024/03/13/2845826/33333/en/Coherus-BioSciences-Reports-Fourth-Quarter-Full-Year-2023-Financial-Results-and-Provides-Current-Business-Update.html

Mar 13, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next